ASP-6282
- Generic Name
- ASP-6282
First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2015-04-20
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- Astellas Pharma Europe B.V.
- Target Recruit Count
- 116
- Registration Number
- NCT02420782
- Locations
- 🇬🇧
Site GB44001, Harrow, United Kingdom
🇩🇪Site DE49001, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath